D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Free Cash Flow Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Free Cash Flow
myr20.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
2%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Free Cash Flow
myr740.3k
CAGR 3-Years
-50%
CAGR 5-Years
-40%
CAGR 10-Years
-8%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Free Cash Flow
myr12.2m
CAGR 3-Years
-36%
CAGR 5-Years
14%
CAGR 10-Years
N/A
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Free Cash Flow
myr24.9m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Free Cash Flow
myr35.2m
CAGR 3-Years
25%
CAGR 5-Years
11%
CAGR 10-Years
14%
K
Kotra Industries Bhd
KLSE:KOTRA
Free Cash Flow
myr20.1m
CAGR 3-Years
-22%
CAGR 5-Years
-4%
CAGR 10-Years
11%

See Also

What is Duopharma Biotech Bhd's Free Cash Flow?
Free Cash Flow
20.1m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Free Cash Flow amounts to 20.1m MYR.

What is Duopharma Biotech Bhd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
2%

Back to Top